HCA Healthcare (HCA) and Intuitive Surgical (ISRG) on Torvanta's measures: HCA grades higher on 2 of the 4 factor families and ISRG on 2.
| HCA | ISRG | |
|---|---|---|
| Value grade | B+ | D |
| Growth grade | C | A- |
| Profitability grade | n/a | B+ |
| Momentum grade | C | C- |
| Market value | n/a | $150.7B |
| P/E (trailing) | n/a | 48.9x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $76.4B | $11.0B |
| Revenue growth (y/y) | n/a | +21% |
| Operating margin | 15.7% | 31.3% |
| Return on invested capital | n/a | 18.6% |
| Free-cash-flow yield | 8.3% | 2.1% |
| Total return, 1 year | +10.1% | -1.8% |
| Total return, 3 years | +96.0% | +55.6% |
Full HCA analysis · Full ISRG analysis
HCA Healthcare (HCA) and Intuitive Surgical (ISRG) on Torvanta's measures: HCA grades higher on 2 of the 4 factor families and ISRG on 2. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings HCA trades at n/a and ISRG at 48.9x; their value grades are B+ and D against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer